Report ID: 10008191 |
Published Date: 21 Mar 2025 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
Definition of Digital Pathology Market
Digital pathology is a computer-enabled image-based information environment that allows for the management of information generated from a digital slide. In recent years, the fields of digital pathology and evaluation of digital whole slide images (WSI) have grown tremendously. It is the study and practice of pathology using digital imaging. In the discipline of pathology, the use of this innovative technology is about to become the standard of care. Static images, live streaming images, and most recently full slide imaging have all been used in digital pathology (WSI). Moreover, it enables pathologists to work at any time from anywhere, making the process more efficient and faster
Global Digital Pathology Market: Key Insights
|
Base Year |
2022 |
|
Forecast Year |
2023-2033 |
|
CAGR |
~10% |
|
Base Year Market Size (2022) |
~ USD 800.0 Million |
|
Forecast Year Market Size (2033) |
~ USD 2,300.0 Million |
|
Regional Scope |
|
Global Digital Pathology Market Highlights Over 2023 - 2033
The global digital pathology market is estimated to garner a revenue of USD 2,300 Million by the end of 2033 by growing at a CAGR of ~10% over the forecast period, i.e., 2023 – 2033. Further, the market generated a revenue of USD 800.0 Million in the year 2022. The growth of the market can be attributed to the rising adoption of digital pathology for disease diagnosis, drug discovery, and others. Moreover, there has been an increasing research and development investment by companies, medical institutes, and others for detecting new diseases, and treatment. For instance, more than 2 Million pathology slices have been scanned in Europe till 2021.
.jpg)
GET A SAMPLE COPY OF THIS REPORT
Digital pathology is a computer-enabled image-based information environment that allows for the management of information generated from a digital slide. In recent years, the fields of digital pathology and evaluation of digital whole slide images (WSI) have grown tremendously. It enables pathologists to work at any time from anywhere, making the process more efficient and faster. Moreover, the growing geriatric population is anticipated to increase the growth of the global digital pathology market. As per the United Nations, there were approximately 703 Million persons in the world aged 65 years or above in the year 2019.
Global Digital Pathology Market: Growth Drivers and Challenges
Growth Drivers
-
The surge in Chronic Disorders – Digital pathology plays an important role in disease diagnosis and it is expected to boost the growth of the global digital pathology market. According to the Centers for Disease Control and Prevention, nearly 6 in 10 adults in the United States have a chronic disease.
-
Growth Need for Cancer Diagnosis – As per the data reported by the World Health Organization, cancer accounted for nearly 10 Million deaths in the year 2020.
-
Increasing Adoption of Artificial Intelligence in Healthcare– Nearly 9 out of 10 hospitals across the globe have an artificial intelligence strategy in their operations.
-
Surging Investment by the Pharmaceutical Industry –There has been surging investment by the pharmaceutical industry and increasing collaborations among the pharma companies. Hence, it is projected to drive the growth of the global digital pathology market. In the year 2020, the global pharmaceutical industry spending on research & development accounted for more than USD 190 Million
Challenges
-
High Cost of the Digital Pathology System
-
Scarcity of Trained Pathologists
Pathology tests are used by health professionals to diagnose diseases. These health professionals should be specially trained staff to conduct the test on an accurate basis. Therefore, it can restrain the growth of the global digital pathology market.
-
Lack of Awareness Related to Digital Pathology
The global digital pathology market is segmented and analyzed for demand and supply by application into disease diagnosis, teleconsultation, drug discovery, and others. Out of these, the drug discovery segment is anticipated to hold the largest share over the forecast period owing to rising research & development expenditure around the globe. According to the World Bank, the research & development expenditure has increased from 1.96 percent in 2005 to 2.63 percent in 2020.
Global Digital Pathology Market Regional Synopsis
Regionally, the global digital pathology market is studied into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. Amongst these markets, the market in the North American region is projected to hold the largest market share by the end of 2033 on the back of the surging adoption of digital pathology for disease diagnosis. Moreover, there has been an improving condition in cancer patients' treatment. As per the National Cancer Institute, there were nearly 18.1 Million cancer survivors in the United States as of January 2022.
Market Segmentation
Our in-depth analysis of the global digital pathology market includes the following segments:
|
By End User |
|
|
By Application |
|
|
By Product Type |
|
Key Companies Dominating the Global Digital Pathology Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global digital pathology market that are included in our report are Danaher Corporation, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd, XIFIN, Inc., Huron Technologies International Inc., Sectra AB, Olympus Corporation, Inspirata, Inc., 3D Hitech Ltd., Visiopharm A/S, and others.
Global Digital Pathology Market: Latest Developments
-
June 2022: F. Hoffmann-La Roche Ltd announced the launch of the VENTANA DP 600 slide scanner that creates a digital image of stained tissue samples in high resolution that help to diagnose cancer and determine a patient’s treatment.
-
November 2021: Olympus Corporation, announced the first results of an artificial intelligence-based pathology diagnostic tool for gastric cancer that has achieved 100 percent sensitivity and 50 percent or more specificity for all gastric biopsy pathology specimens analyzed.
Frequently Asked Question
The market is segmented by application, product type, end user, and by region.
The drug discovery segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
Report ID: 10008191 |
Published Date: 21 Mar 2025 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
